Recorded—October 16, 2007  ¦  7:00PM to 9:30PM Eastern time

Available on DVD for $24.95

Statement of Need

There are many health consequences that result directly from the spasticity and movement disorders commonly seen in persons with cerebral palsy. Two of these important consequences are oral health disorders and polypharmacy, both of which can lead to serious morbidity and even mortality in persons with cerebral palsy.

Primary care and specialist physicians, and other associated health professionals, such as nurses and physical therapists, need to understand how spasticity and movement disorders experienced by persons with cerebral palsy create an increased risk for dental problems and unnecessary polypharmacy, so that these problems can be avoided whenever possible.

Conference Goal

The overall goal of this conference is to improve clinical knowledge, skills, and competency of those health professionals that provide services to adults and children with cerebral palsy.

Educational Objectives

Upon completion of this educational activity, participants will be able to:

• Discuss the evaluation and management of oral health disorders frequently encountered in persons with cerebral palsy.
• Explain why persons with cerebral palsy are at risk for unnecessary polypharmacy.
• Describe examples of drug-drug interactions which can lead to clinical toxicity in persons with cerebral palsy.

Program Agenda and Faculty

6:30-7:00 PM:

Registration/sign on

7:00-7:15 PM:

Introduction and Overview

Seth M. Keller MD

7:15-8:00 PM:

Oral Health Disorders as a Health Consequence of Spasticity and Movement Disorders Associated with Cerebral Palsy.

Carlton Horbelt DDS, FADPD

8:00-8:45 PM:

The Problem of Polypharmacy and Drug Toxicity in Persons with Cerebral Palsy

Ann Tilton MD

8:45-9:30 PM:

Questions and Discussion

Faculty

UTCOM-Chattanooga reserves the right to modify the program contents, faculty, and program activities. It also reserves the right to cancel the program if necessary.

Grantor Support

Supported by an unrestricted educational grant from Allergan Pharmaceuticals, Inc.

Who Should Attend

Pediatricians, Internists, Family Practitioners, Neurologists, Nurses, Physical Therapists, Occupational Therapists.

Accreditation Statement

The UTCOM-Chattanooga is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for physicians.

The American Academy of Developmental Medicine & Dentistry is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing education for physicians.

Credit Designation Statement

UTCOM-Chattanooga designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive AMA PRA Category 1 Credits™, physicians must attend the entire 2.5 hour conference, complete the CME Evaluation Form. This form will be made available at the time of the conference online.

Disclosure Policy

UTCOM-Chattanooga requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the program. This information will be made available to the audiences prior to the presentation.

Activity Co-Directors

Chris Prater MD

Associate Clinical Professor of Medicine
Department of Family Medicine
UT College of Medicine-Chattanooga

Rick Rader MD

President,
American Academy of Developmental Medicine & Dentistry
Editor-in-Chief, EP Magazine

Philip B. May MD

Clinical Associate Professor of Medicine,
UMDNJ-Robert Wood Johnson Medical School
Assistant Medical Director,
Hunterdon Developmental Center
Director of Medical Education,
American Academy of Developmental Medicine and Dentistry

Help Desk

Copyright 2007
Exceptional Parent and
Vemics, Inc.
All rights reserved.